Meg Jardine's Publications
About Meg Jardine's Publications
Honorary Professorial Fellow, The George Institute for Global Health- Associate Professor, Faculty of Medicine, UNSW Sydney
-
Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program
Endocrinology, Diabetes & Metabolism Date published: -
Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial
Diabetes, Obesity and Metabolism Date published: -
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial
American Heart Journal Date published: -
The International Society of Nephrology Advancing Clinical Trials (ISN-ACT) Network: current activities and future goals
Kidney International Date published: -
Innovating and invigorating the clinical trial infrastructure for glomerular diseases
Kidney International Date published: -
Kidney, Cardiovascular, and Safety Outcomes of Canagliflozin according to Baseline Albuminuria
Clinical Journal of the American Society of Nephrology Date published: -
Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use: a post hoc analysis from the CANVAS Program
ESC Heart Failure Date published: -
An exploration of the heterogeneity in effects of SGLT2 inhibition on cardiovascular and all-cause mortality in the EMPA-REG OUTCOME, CANVAS Program, DECLARE-TIMI 58, and CREDENCE trials
International Journal of Cardiology Date published: -
Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
Kidney International Reports Date published: -
ANTIPLATELET AGENTS FOR CHRONIC KIDNEY DISEASE: AN UPDATED COCHRANE REVIEW
Date published: -
MEDIATORS OF THE EMPAGLIFLOZIN TREATMENT EFFECT ON KIDNEY OUTCOMES IN THE EMPA-REG OUTCOME TRIAL
Date published: -
Comparative Effectiveness of SGLT2i Versus GLP1-RA on Cardiovascular Outcomes in Routine Clinical Practice
SSRN Electronic Journal Date published: -
Comparative Effectiveness of SGLT2i Versus DPP4i on Cardiovascular, Kidney and Hyperkalemia Outcomes in Individuals from Routine Clinical Practice: Observational Cohort Study
SSRN Electronic Journal Date published: -
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics
American Journal of Nephrology Date published: -
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program
American Journal of Kidney Diseases Date published: -
The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes
Diabetes, Obesity and Metabolism Date published: